Free Trial

Lantern Pharma (LTRN) Short Interest Ratio & Short Volume

Lantern Pharma logo
$2.94 -0.14 (-4.55%)
(As of 11/20/2024 ET)

Lantern Pharma Short Interest Data

Lantern Pharma (LTRN) has a short interest of 165,600 shares, representing 2.06% of the float (the number of shares available for trading by the public). This marks a -6.39% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.9, indicating that it would take 3.9 days of the average trading volume of 47,499 shares to cover all short positions.

Current Short Interest
165,600 shares
Previous Short Interest
176,900 shares
Change Vs. Previous Month
-6.39%
Dollar Volume Sold Short
$517,500.00
Short Interest Ratio
3.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
10,780,000 shares
Float Size
8,030,000 shares
Short Percent of Float
2.06%
Today's Trading Volume
71,698 shares
Average Trading Volume
47,499 shares
Today's Volume Vs. Average
151%
Short Selling Lantern Pharma?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Lantern Pharma and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

LTRN Short Interest Over Time

LTRN Days to Cover Over Time

LTRN Percentage of Float Shorted Over Time

Lantern Pharma Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024165,600 shares $517,500.00 -6.4%2.1%3.9 $3.13
10/15/2024176,900 shares $626,226.00 -6.9%2.2%3.8 $3.54
9/30/2024190,000 shares $697,300.00 +6.1%2.4%3.8 $3.67
9/15/2024179,100 shares $719,982.00 -19.8%2.2%3.3 $4.02
8/31/2024223,300 shares $913,297.00 -4.2%2.8%3.6 $4.09
8/15/2024233,000 shares $999,570.00 +11.0%2.9%3.5 $4.29
7/31/2024210,000 shares $882,000.00 -13.8%2.6%2.8 $4.20
7/15/2024243,500 shares $1.06 million -21.2%3.1%2.7 $4.35
6/30/2024308,900 shares $1.44 million -7.4%3.9%2.7 $4.67
6/15/2024333,500 shares $1.79 million -20.6%4.2%2 $5.37
5/31/2024419,800 shares $2.55 million -3.4%5.3%1.7 $6.07
5/15/2024434,400 shares $2.75 million -10.3%5.5%1.3 $6.33
4/30/2024484,300 shares $2.47 million -2.6%6.2%1.5 $5.10
4/15/2024497,300 shares $2.97 million +18.2%6.3%1.6 $5.97
3/31/2024420,900 shares $3.70 million +191.1%5.3%1.5 $8.80
3/15/2024144,600 shares $1.26 million +112.7%1.8%0.6 $8.70
2/29/202468,000 shares $327,080.00 +14.1%0.9%0.5 $4.81
2/15/202459,600 shares $238,996.00 -14.2%0.8%1.6 $4.01
1/31/202469,500 shares $293,290.00 -4.3%0.9%1.6 $4.22
1/15/202472,600 shares $295,482.00 +17.1%1.0%1.6 $4.07
12/31/202362,000 shares $265,360.00 -65.7%0.8%1.4 $4.28
12/15/2023180,500 shares $776,150.00 -20.1%2.4%4.3 $4.30
11/30/2023226,000 shares $892,700.00 +25.0%3.0%5.9 $3.95
11/15/2023180,800 shares $725,008.00 +19.7%2.4%5.1 $4.01
10/31/2023151,000 shares $374,480.00 -2.6%2.0%5.8 $2.48
10/15/2023155,000 shares $509,950.00 +0.1%2.1%5.9 $3.29
9/30/2023154,800 shares $527,868.00 -0.3%2.1%4.9 $3.41
9/15/2023155,200 shares $630,112.00 -3.5%2.1%4.1 $4.06
8/31/2023160,800 shares $726,816.00 +2.9%2.2%3.8 $4.52
8/15/2023156,200 shares $729,454.00 +9.4%2.1%3.6 $4.67
7/31/2023142,800 shares $661,164.00 -2.9%1.9%3.3 $4.63
7/15/2023147,100 shares $728,145.00 +5.2%2.0%3.6 $4.95
6/30/2023139,900 shares $789,036.00 +0.1%1.9%3.9 $5.64
6/15/2023139,800 shares $826,218.00 -0.1%1.9%4.6 $5.91
5/31/2023139,900 shares $728,879.00 -0.9%1.9%4.8 $5.21
5/15/2023141,200 shares $748,360.00 +0.7%1.9%5.2 $5.30
4/30/2023140,200 shares $686,980.00 -2.4%2.1%5.6 $4.90
4/15/2023143,600 shares $722,308.00 -0.4%2.1%5.1 $5.03
3/31/2023144,200 shares $696,486.00 +0.9%2.1%4.7 $4.83
3/15/2023142,900 shares $661,627.00 +0.4%2.1%3.7 $4.63
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
2/28/2023142,400 shares $781,761.76 -0.8%2.1%3.9 $5.49
2/15/2023143,500 shares $777,770.00 -14.3%2.0%4.1 $5.42
1/31/2023167,400 shares $1.01 million -2.0%2.3%2.9 $6.02
1/15/2023170,800 shares $935,984.00 +15.7%2.3%3 $5.48
12/30/2022147,600 shares $891,504.00 -1.0%2.0%2.6 $6.04
12/15/2022149,100 shares $814,086.00 +2.8%2.0%2.9 $5.46
11/30/2022145,000 shares $725,000.00 -2.1%2.0%3 $5.00
11/15/2022148,100 shares $827,879.00 -3.0%1.8%3.1 $5.59
10/31/2022152,700 shares $639,813.00 -1.0%1.9%3.5 $4.19
10/15/2022154,300 shares $742,183.00 +57.9%2.0%6.3 $4.81
9/30/202297,700 shares $467,006.00 +53.6%1.2%2.5 $4.78
9/15/202263,600 shares $318,636.00 -2.8%0.8%1.7 $5.01
8/31/202265,400 shares $338,118.00 -26.9%0.8%1.8 $5.17
8/15/202289,500 shares $581,750.00 -5.3%1.1%2.4 $6.50
7/31/202294,500 shares $484,785.00 +59.6%1.2%2.5 $5.13
7/15/202259,200 shares $319,088.00 -7.2%0.8%1.6 $5.39
6/30/202263,800 shares $364,298.00 -18.0%0.9%2.9 $5.71
6/15/202277,800 shares $390,556.00 -13.3%1.1%3.5 $5.02
5/31/202289,700 shares $519,363.00 -40.4%1.2%4 $5.79
5/15/2022150,500 shares $880,425.00 -6.2%2.1%5.9 $5.85
4/30/2022160,400 shares $955,984.00 -12.1%2.2%6.2 $5.96
4/15/2022182,400 shares $1.25 million -3.0%2.5%5.2 $6.88
3/31/2022188,000 shares $1.34 million -9.7%2.5%4.1 $7.15
3/15/2022208,200 shares $1.27 million -7.0%2.8%3.2 $6.10
2/28/2022223,900 shares $1.38 million +0.2%2.9%2.9 $6.16
2/15/2022223,400 shares $1.52 million -4.0%2.9%2.7 $6.81
1/31/2022232,700 shares $1.55 million -5.7%3.0%2.6 $6.65
1/15/2022246,800 shares $1.79 million +13.4%3.2%2.7 $7.27
12/31/2021217,700 shares $1.74 million +15.0%2.8%2.6 $7.98
12/15/2021189,300 shares $1.48 million -17.7%2.4%2.3 $7.81
11/30/2021230,100 shares $1.94 million +20.5%3.0%3.4 $8.44
11/15/2021190,900 shares $1.84 million -15.6%2.5%2.5 $9.66
10/29/2021226,200 shares $2.31 million +8.1%2.9%2.8 $10.21
10/15/2021209,300 shares $2.10 million -10.6%2.7%2.6 $10.01
9/30/2021234,000 shares $2.62 million -10.9%3.0%2.7 $11.18
9/15/2021262,700 shares $3.17 million -2.7%3.4%3.4 $12.08
8/31/2021270,100 shares $3.81 million +0.2%3.5%3.6 $14.09
8/13/2021269,700 shares $3.40 million -5.2%3.5%4.3 $12.60
7/30/2021284,600 shares $3.67 million -14.2%3.7%4.9 $12.90
7/15/2021331,800 shares $4.43 million -0.8%4.3%5.4 $13.35
6/30/2021334,500 shares $4.88 million -15.8%4.3%5.1 $14.60
6/15/2021397,100 shares $5.98 million +0.5%5.1%5.1 $15.07
5/28/2021395,000 shares $5.97 million +27.0%5.1%3.9 $15.12
5/14/2021311,100 shares $4.29 million +0.6%4.0%2.6 $13.80
4/30/2021309,400 shares $4.89 million +33.7%4.0%2.3 $15.81
4/15/2021231,500 shares $3.72 million +1.5%3.0%1.4 $16.08
3/31/2021228,000 shares $4.11 million +40.0%3.0%1 $18.02
3/15/2021162,900 shares $3.09 million +45.3%2.2%0.8 $18.97
2/26/2021112,100 shares $1.89 million -6.6%1.6%0.6 $16.87
2/12/2021120,000 shares $2.23 million +41.3%1.7%0.7 $18.61
When it comes to NVDA… “acceleration cycles” are the key (Ad)

Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.

Use this link to see Nvidia Unchained right away!
1/29/202184,900 shares $1.26 million -50.2%1.3%0.6 $14.86
1/15/2021170,400 shares $2.47 million No Change4.4%1.4 $14.51

LTRN Short Interest - Frequently Asked Questions

What is Lantern Pharma's current short interest?

Short interest is the volume of Lantern Pharma shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 165,600 shares of LTRN short. 2.06% of Lantern Pharma's shares are currently sold short. Learn More on Lantern Pharma's current short interest.

What is a good short interest ratio for Lantern Pharma?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LTRN shares currently have a short interest ratio of 4.0. Learn More on Lantern Pharma's short interest ratio.

What is a good short interest percentage for Lantern Pharma?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.06% of Lantern Pharma's floating shares are currently sold short.

Is Lantern Pharma's short interest increasing or decreasing?

Lantern Pharma saw a decline in short interest in the month of October. As of October 31st, there was short interest totaling 165,600 shares, a decline of 6.4% from the previous total of 176,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Lantern Pharma's float size?

Lantern Pharma currently has issued a total of 10,780,000 shares. Some of Lantern Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Lantern Pharma currently has a public float of 8,030,000 shares.

How does Lantern Pharma's short interest compare to its competitors?

2.06% of Lantern Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Lantern Pharma: BioXcel Therapeutics, Inc. (0.81%), Tonix Pharmaceuticals Holding Corp. (5.59%), ProPhase Labs, Inc. (0.65%), Leap Therapeutics, Inc. (3.54%), Skye Bioscience, Inc. (8.88%), Telomir Pharmaceuticals, Inc. (3.22%), Candel Therapeutics, Inc. (9.04%), Adverum Biotechnologies, Inc. (13.39%), Compugen Ltd. (1.42%), Cardiol Therapeutics Inc. (1.23%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Lantern Pharma stock?

Short selling LTRN is an investing strategy that aims to generate trading profit from Lantern Pharma as its price is falling. LTRN shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Lantern Pharma?

A short squeeze for Lantern Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LTRN, which in turn drives the price of the stock up even further.

How often is Lantern Pharma's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LTRN, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:LTRN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners